RaySearch Laboratories (Q2 Initial take): Confidence in a strong H2 - Redeye

RaySearch’s Q2 figures were largely known following the July profit warning. More importantly, management reiterates its full-year EBIT margin target of +25%, while the recently announced US orders provide a strong signal that the Q2 delays were indeed timing related. We continue to expect a significantly stronger H2 2026.

Länk till analysen i sin helhet: https://www.redeye.se/research/1178976/raysearch-laboratories-q2-initial-take-confidence-in-a-strong-h2?utm_source=finwire&utm_medium=RSS